Close
CDMO Safety Testing 2026
Novotech

Alliance4Growth, an Advisory and Transactional Consulting Firm, Announces Its Participation to BIO 2012

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

Holista Launches Collagen Production JV With SCC in Collie

Holista Colltech Limited has entered into a binding joint...

AddParts Secures Funding for Pharma Manufacturing Resilience

AddParts, a UK-based technology company focused on improving operational...

Made Smarter Advances AI in Manufacturing with New Toolkit

A new initiative from Made Smarter is aiming to...
- Advertisement -

The recently formed strategic, transactional and operational advisory firm, Alliance4Growth (A4G), is pleased to announce its participation to the BIO US conference, a premier venue in the Life Sciences and Biotechnology arenas, in support to its endeavors with a variety of clients.

Dr. Bernard Cambou, Managing Partner โ€“ US Office, who resides in the United States since 1995, will attend this important conference to initiate various partnering initiatives in support to clientsโ€™ international development initiatives.

โ€œTraditional venture investing is a thing of the pastโ€

โ€œThe life sciences arena is rapidly changing and the โ€œgoing aloneโ€ model of the past does not apply anymoreโ€ says Dr. Gilles Avenard, Managing Partner. He stresses that โ€œin a complex, challenging and ever-changing financial and industrial environment, the biotechnology and pharmaceutical companies are more and more looking for partners to sustain their growth and remain at the cutting-edge in this very competitive and fully globalised field. Our core expertise is to advise them and act upon innovative solutions that create both industrial and financial perspectives. We believe that the long term viability of highly innovative companies, today more than ever, requires means to establish value of the assets, secure alliances, and reach critical size at an earlier stageโ€.

A synergistic array of competencies

Thanks to the combined competencies of its 4 original founders, A4G is well-equipped to intervene in most if not all aspects that relate to growth, monetization of assets as well as operational risk-mitigation in the life sciences, biotechnology and pharmaceutical sectors. Typical assignments that A4G is conducting today are:

– R&D, industrial and commercial partnering in various geographies

– Clinical/regulatory strategy

– Monetization of broad patent portfolio

– Financings

– Asset disposal

– Buy-out

– Licensing

– Implementation of a US-based commercial and operational business

A4G at a glance:

Alliance4growth is a strategic advice firm dedicated to the field of innovative pharmaceutical and medical technology solutions. Alliance4Growth is headquartered in Paris, France. It operates in the US from its office in Pittsburgh, PA.

ย 

ย 

ย 

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast โ€“ stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Latest stories

Related stories

Holista Launches Collagen Production JV With SCC in Collie

Holista Colltech Limited has entered into a binding joint...

AddParts Secures Funding for Pharma Manufacturing Resilience

AddParts, a UK-based technology company focused on improving operational...

Made Smarter Advances AI in Manufacturing with New Toolkit

A new initiative from Made Smarter is aiming to...

Teva Adds Ecopipam Therapy in $700M Emalex Acquisition Deal

Teva Pharmaceuticals has entered into a definitive agreement to...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป